Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Horses still struggling with skin problems - survey
The most commonly reported skin problems were sweet itch and mud fever.

Blue Cross and BEVA publish results of 2018 equine health survey 

Skin problems remain the most commonly reported health issue in horses, according to figures from the 2018 National Equine Health Survey (NEHS).

The survey reveals that skin diseases accounted for 33 per cent of all problems reported in 2018 (31 per cent in 2017), followed by lameness (29 per cent), metabolic diseases (7.4 per cent), respiratory disease (7 per cent) and eye problems (6 per cent).

The most commonly reported skin problems were sweet itch and mud fever, accounting for 42.7 per cent of all skin diseases. Sarcoids and melanoma were also commonly reported (4.6 per cent and 1.5 per cent respectively). Wounds accounted for 9.3 per cent of skin problems recorded.

The NEHS was created in 2010 by Blue Cross, BEVA and RVC Professor of Equine Clinical Studies, Josh Slater. Supported by the major UK equestrian organisation, the survey offers a snapshot of disease prevalence at the same time every year.

The NEHS relies on survey feedback from thousands of horse owners across the UK and helps to pinpoint trends in equine epidemic diseases. The results are used by vets and researchers as benchmarks for our general knowledge of horse health.

Some 5,500 people took part in the survey this year, returning records for almost 14,000 horses. The figures, which are similar to returns for previous years, enable an initial breakdown into general disease syndromes and then a further breakdown into individual diseases.

British Horse Society director of welfare Gemma Stanford said: “The BHS has been wholly supportive of this valuable survey since its inception. The information it has generated over the past eight years has been enlightening and gives all of us within the industry a valuable guide to the most significant endemic diseases affecting our horses today.”

Olympian eventer Mary King added: “The health and happiness of our equine population are of great importance to me, and Blue Cross’s NEHS survey has helped us gain a true understanding of the state of our nation’s horses to help improve their welfare.”

Image (C) Bright Bay Consulting

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.